Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![boobuddycrypto Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::478320322.png) boobuddy [@boobuddycrypto](/creator/twitter/boobuddycrypto) on x XXX followers
Created: 2025-07-14 07:52:54 UTC

Meet Ivonescimab, made by 🇨🇳 biotech firm Akeso.

It’s the world’s first PD-1/VEGF bispecific antibody — combining two cancer-fighting weapons in one:

PD-1: supercharges immune system

VEGF: blocks tumor blood supply

One drug. Two attacks.


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1944666400376897762/c:line.svg)

**Related Topics**
[the worlds](/topic/the-worlds)
[blocks](/topic/blocks)
[$9926hk](/topic/$9926hk)

[Post Link](https://x.com/boobuddycrypto/status/1944666400376897762)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

boobuddycrypto Avatar boobuddy @boobuddycrypto on x XXX followers Created: 2025-07-14 07:52:54 UTC

Meet Ivonescimab, made by 🇨🇳 biotech firm Akeso.

It’s the world’s first PD-1/VEGF bispecific antibody — combining two cancer-fighting weapons in one:

PD-1: supercharges immune system

VEGF: blocks tumor blood supply

One drug. Two attacks.

XX engagements

Engagements Line Chart

Related Topics the worlds blocks $9926hk

Post Link

post/tweet::1944666400376897762
/post/tweet::1944666400376897762